Current and Future Cancer Research Objectives

On December 26th, 2017, posted in: Cancer 101 by

The Cancer Moonshot Initiative:
Current and Future Cancer Research Objectives

October 4, 2017

On October 27, 2016, the Cancer Moonshot Blue Ribbon Panel released its report that represented the merger of science, technology, advocacy, social science, and big data coming together to solve cancer’s greatest challenges. A bipartisan Congress provided $1.8 billion in funding over seven years for the initiative as part of the 21st Century Cures Act. The National Cancer Institute has announced the first series of research projects to be conducted through the Beau Biden Cancer Moonshot program.

On October 4, 2017, the National Coalition for Cancer Research conducted a “Cancer 101” Congressional briefing to highlight the first year of progress achieved through the Cancer Moonshot initiative, and to discuss future objectives of the program.

Speakers for the briefing were:

  • Douglas R. Lowy, M.D., Acting Director, National Cancer Institute;\
  • Thomas J. Lynch, M.D., Executive Vice President, Chief Scientific Officer, Oncology, Bristol-Myers Squibb;
  • Peter J. O’Dwyer, M.D., Director, Developmental Therapeutics Program, Abramson Cancer Center, Hospital of the University of Philadelphia; Professor of Medicine, Hospital of the University of Pennsylvania, Presbyterian Medical Center of Philadelphia;
  • Richard Schilsky, M.D., FACP, FASCO, Senior Vice President of Center for Research & Analytics and Chief Medical Officer, American Society of Clinical Oncology; and
  • Jacqueline D. Smith, MA, MS, Cancer Survivor, Policy and Advocacy Manager, Society for Immunotherapy of Cancer.
No Responses to “Current and Future Cancer Research Objectives”

Leave a Reply